Elanco Vira Shield 6 + L5

Durvet

Options

Vira Shield 6 VL5 HB Somnus has been shown to be effective for the vaccination of healthy cattle against disease caused by Bovine Viral Diarrhea (BVD) Type 1 and 2, Infectious Bovine Rhinotracheitis (IBR), Bovine Parainfluenza₃ (PI₃), Bovine Respiratory Syncytial Virus (BRSV), Campylobacter (Vibrio) fetus, L. canicola, L. grippotyphosa, L. hardjo-prajitno, L. icterohaemorrhagiae and L. pomona.

The duration of immunity for BVD Type 2 is at least 11 months and for C. fetus and L. hardjo‑bovis is at least 12 months. The durations of immunity for the other antigens in this product has not been determined.

For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. This product is safe for use in pregnant cows and heifers.

As a research-proven, safe and powerful line of inactivated vaccines, Vira Shield® provides comprehensive protection against up to 13 respiratory and reproductive pathogens. Plus, research has shown that Vira Shield allows cows to have improved reproductive performance.¹ Which means you can stress less knowing your herd will be protected and can maintain production.

Key Benefits:

Stress less about conception rates with a 6.5% higher first-service conception rate compared to a competitive modified-live virus vaccine¹
Stress less about disease with comprehensive protection against up to 13 respiratory and reproductive pathogens
Stress less about stress. Vira Shield is easy to implement in any management program or whole-herd protocol

Directions

Shake well before using. Administer 5 mL subcutaneously two to four weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate according to label and use directions in four to five weeks. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency, consultation with a veterinarian is recommended.

For all vaccine products: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.

Precautions

Store out of direct sunlight at 2 to 8°C (35 to 46°F). DO NOT FREEZE.

Use entire contents when first opened. Do not mix with other products, except as specified on this label.

In case of human exposure, contact a physician.

Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for three to six days following vaccination.

Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.